Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2dfe7cad2c7005393f016e6f9bb88592 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00 |
filingDate |
2004-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95a9af30b253c889be2728da7a2a2c56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86a3f69a238adb5e4cf8bd84d1ec6e84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2b719317162e4d4e3988b8ae70cefd4 |
publicationDate |
2006-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1703938-A1 |
titleOfInvention |
Method of treatment for undesired effect following transdermal or topical drug delivery |
abstract |
This invention relates to a method for inhibiting the percutaneous absorption of a physiologically active agent topically applied to a transdermal administration site of a subject, the method including the step of applying to skin of the subject at the transdermal administration site, a device (1, 7) comprising a membrane (8) for contacting the skin of the subject coated on the skin contacting side thereof (11) with a layer of an adhesive (10). |
priorityDate |
2003-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |